products
products
that
promote healing.
products
that
promote healing.
ECI develops breakthrough products for eye care, wound care, and burn healing that leverage its plasma and chitosan platform technology to help patients see clearly and live healthier lives.
products
Our therapeutic formulation is suitable for a variety of products, including liquid eye drops, gels, ointments, contact lenses, contoured bandages, and wound dressings. We believe this formulation will promote healing of epithelial (surface cell) disorders, such as dry eye disease, ophthalmic burns, and chronic wounds.
platform
Our platform leverages plasma from donated human blood and a proprietary antimicrobial molecule (form of chitosan). The tissue-repairing benefits of plasma-derived products, combined with the sustained action of chitosan, may provide relief and long-lasting therapeutic action.
patients
Patients who experience conditions ranging from dry eye disease, to diabetic ulcers, and wounds or burns may benefit from our fusion of plasma and chitosan as a forward-thinking and potent strategy to potentially address their conditions with easier access and fewer side effects.
Dry Eye Patients (US)
0
There are 22 million dry eye patients in the United States
and of those only 8 million are treated,
with 50% discontinuing treatment, largely due to dissatisfaction.
Dry Eye Patients (US)
0
There are 22 million dry eye patients in the United States
and of those only 8 million are treated,
with 50% discontinuing treatment, largely due to dissatisfaction.
Dry Eye Patients (US)
0
There are
22 million dry eye patients
in the United States
and of those
only 8 million are treated,
with 50% discontinuing treatment,
largely due to dissatisfaction.
people
Our team is comprised of experts in blood banking / hematology, ophthalmology, and biomedical/biomaterial engineering.
Interested in joining us on our mission? Learn about our culture and explore opportunities to be part of our story.
We hope you like coffee and puppies!